JDDW2019 Close
Keyword Search
Adding space between the words will produce results as inserting the word "AND".
International Session(Symposium)8(JGES・JSGE・JSGS・JSGCS)
Sat. November 23rd   14:30 - 17:00   Room 11: Portopia Hotel South Wing Topaz
IS-S8-4_E
Pan-enteroscopic survey for post allogeneic hematopietic stem cell transplantation by using colon capsule endoscopy
Ryoichi Miyanaga1, Naoki Hosoe2, Haruhiko Ogata2
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 2Center for Diagnostic and Therapeutic Endoscopy, Keio University
Background and study aim: Graft-versus-host disease (GVHD) and cytomegalovirus (CMV) infection occur in the whole gastorointestinal (GI) tract in post allogeneic haematopoietic stem cell transplantation (allo-HSCT). Colon capsule endoscopy (CCE) can obtain through GI tract images non-invasively. The study aim was to evaluate the efficacy of pan-enteric survey with CCE for post allo-HSCT.
Patients and methods: This was a prospective observational study. CCE using PillCam COLON2® was performed for pan-enteroscopy on the day 21-28 post allo-HSCT. If CCE images showed suspicious of GVHD and/or CMV infection, or the patients had abdominal symptoms, conventional endoscopy and/or enteroscopy and histological examination were performed. If CCE did not show abnormal findings nor GI symptoms until the day 60, the patient was defined as free of GVHD and/or CMV infection.
Results: 30 patients were scheduled for enrollment. All CCE reached colon. The per site sensitivity, specificity and accuracy of CCE findings compared with endoscopy and/or enteroscopy were 73%, 99% and 90%, respectively. The per patient sensitivity, specificity and accuracy of CCE for any findings were 58%, 86% and 73%, respectively. In CCE finding positive group, there was a tendency to be diagnosed as histopathology GVHD and/or CMV infection.
Conclusions: Pan-enteric survey using CCE was applicable for post allo-HSCT.
Index Term 1: Colon Capsule endoscopy
Index Term 2: Graft-versus-host disease
Page Top